Education
About Us
Working with TipRanks
Follow Us
Noile-Immune Biotech Inc. (JP:4893)
:4893
4893 Stock Chart & Stats
¥132.00
¥9.00(4.81%)
At close: 4:00 PM EST
¥132.00
¥9.00(4.81%)
Day’s Range― - ―
52-Week Range¥120.00 - ¥229.00
Previous CloseN/A
Volume1.93M
Average Volume (3M)85.17K
Market Cap
¥5.71B
Enterprise Value¥3.68B
Total Cash (Recent Filing)¥4.31B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.46
Shares Outstanding43,276,764
10 Day Avg. Volume110,290
30 Day Avg. Volume85,173
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)1.56
Price to Sales (P/S)970.16
P/FCF Ratio-8.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-4,366.81
Revenue Forecast (FY)¥46.79B
4893 FAQ
What was Noile-Immune Biotech Inc.’s price range in the past 12 months?
Noile-Immune Biotech Inc. lowest stock price was ¥120.00 and its highest was ¥229.00 in the past 12 months.
What is Noile-Immune Biotech Inc.’s market cap?
Noile-Immune Biotech Inc.’s market cap is ¥5.71B.
When is Noile-Immune Biotech Inc.’s upcoming earnings report date?
Noile-Immune Biotech Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 49 days.
How were Noile-Immune Biotech Inc.’s earnings last quarter?
Noile-Immune Biotech Inc. released its earnings results on Nov 13, 2025. The company reported -¥4.46 earnings per share for the quarter, beating the consensus estimate of -¥11.04 by ¥6.58.
Is Noile-Immune Biotech Inc. overvalued?
According to Wall Street analysts Noile-Immune Biotech Inc.’s price is currently Overvalued.
Does Noile-Immune Biotech Inc. pay dividends?
Noile-Immune Biotech Inc. does not currently pay dividends.
What is Noile-Immune Biotech Inc.’s EPS estimate?
Noile-Immune Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noile-Immune Biotech Inc. have?
Noile-Immune Biotech Inc. has 43,276,764 shares outstanding.
What happened to Noile-Immune Biotech Inc.’s price movement after its last earnings report?
Noile-Immune Biotech Inc. reported an EPS of -¥4.46 in its last earnings report, beating expectations of -¥11.04. Following the earnings report the stock price went up 0.641%.
Which hedge fund is a major shareholder of Noile-Immune Biotech Inc.?
Currently, no hedge funds are holding shares in JP:4893
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Technical Analysis
OncoTherapy Science
―
Cytori Cell Research Institute, Inc.
―
Oncolys BioPharma, Inc.
―
Delta-Fly Pharma, Inc.
―
Kringle Pharma, Inc.
―